Archives of Medical Research
Volume 37, Issue 6 , Pages 700-708 , August 2006

Trimetazidine-Induced Enhancement of Myocardial Recovery during Reperfusion: A Comparative Study in Diabetic and Non-diabetic Rat Hearts

  • Murat Ikizler

      Affiliations

    • Department of Cardiovascular Surgery, Osmangazi University, Medical Faculty, Eskisehir, Turkey
    • Corresponding Author InformationAddress reprint requests to: Dr. Murat Ikizler, Visnelik Mh. Karatay Sk., No:3/31, 26020, Eskisehir, Turkey
    • ,
  • Nilufer Erkasap

      Affiliations

    • Department of Physiology, Osmangazi University, Medical Faculty, Eskisehir, Turkey
    • ,
  • Sadettin Dernek

      Affiliations

    • Department of Cardiovascular Surgery, Osmangazi University, Medical Faculty, Eskisehir, Turkey
    • ,
  • Bulent Batmaz

      Affiliations

    • Anatolian University, Open-Education Faculty, Eskisehir, Turkey
    • ,
  • Tugrul Kural

      Affiliations

    • Department of Cardiovascular Surgery, Osmangazi University, Medical Faculty, Eskisehir, Turkey
    • ,
  • Ziya Kaygisiz

      Affiliations

    • Department of Physiology, Osmangazi University, Medical Faculty, Eskisehir, Turkey

Received 13 October 2005 ,Accepted 23 January 2006.

References 

  1. Wagner AM, Rubio M, Llanas O, Perez AP. Diabetes mellitus and cardiovascular disease. Eur J Med. 2002;13:15–30
  2. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–1146
  3. Webster MWI, Scott RS. What cardiologist needs to know about diabetes?. Lancet. 1997;350(Suppl 1):123–127
  4. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–444
  5. Woodfield SL, Lundengan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction. The GUSTO-I experience. J Am Coll Cardiol. 1996;28:1661–1669
  6. Barzilay JI, Kronmal RA, Bittner V, Eaker E, Evans C, Foster ED. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the coronary Artery Surgery Study [CASS] Registry). Am J Cardiol. 1994;74:334–339
  7. Barrett EJ, Schwertz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest. 1948;74:1073–1079
  8. Piot C. Metabolic considerations in the treatment of coronary disease in diabetic patients. Diabetes Metab. 2001;27(5Pt 2):25–29
  9. Papadakis JA, Millionis HJ, Press M, Mikhailidis DP. Treating dyslipidaemia in non-insulin dependent diabetes mellitus—a special reference to statins. J Diabetes Complic. 2001;15:211–226
  10. Marzilli M. Management of ischemic heart disease in diabetic patients—is there a role for cardiac metabolic agents. Curr Med Res Opin. 2001;17:1–6
  11. Boddeke E, Hugtenburg J, Jap W, Heynis J, van Zwieten P. New anti-ischaemic drugs. Cytoprotective action with no primary hemodynamic effects. Trends Pharmacol Sci. 1989;10:379–400
  12. Leris J, Boucher F. Rationale for trimetazidine administration in myocardial ischemia-reperfusion syndrome. Eur Heart J. 1993;14:34–40
  13. Kantor PF, Luvien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2000;86:580–588
  14. Rosano GMC, Vitale C, Sposato B, Mercuro G, Fini M. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study. Cardiovasc Diabetol. 2003;2:16
  15. Rafsanjani FN, Vahedian J. The effect of insulin-dependent diabetes mellitus on basal and distention-induced acid and pepsin secretion in rat. Diabetes Res Clin Pr. 2004;16:1–6
  16. Pantos C, Bescond-Jacquet A, Tzeis S, Paizis I, Mourouzis I, Moraitis P, et al. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner. Basic Res Cardiol. 2005;100:154–160
  17. Fragasso G, Piatti PM, Monti L, Palloshi A, Setola E, Puccetti P, et al. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. Am Heart J. 2003;146(5):E18
  18. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Prob Cardiol. 1994;19:59–113
  19. Das I. Effects of heart work and insulin on glycogen metabolism in the perfused rat heart. Am J Physiol. 1973;224:7–12
  20. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res. 1997;33:243–257
  21. Lopaschuk GD. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?. Coron Artery Dis. 2001;12:8–11
  22. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res. 1997;34:25–33
  23. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;ii:785–789
  24. Lopaschuk GD, Wambolt RB, Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemia hearts. J Pharmacol Exp Ther. 1993;264:135–144
  25. Wieland O, Siess E, Schulze-Wethmar FH, Funcke HG, Winton B. Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: effect of diabetes, fasting and refeeding on pyruvate dehydrogenase interconversion. Arch Biochem Biophys. 1971;143:593–601
  26. Lavanchy N, Martin J, Rossi A. Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart. Arch Int Pharmacodyn Ther. 1987;286:97–110
  27. Renaud JF. Internal pH, Na+ and Ca2+ regulation by trimetazidine during cardiac cell acidosis. Cardiovasc Drugs Ther. 1988;1:677–686
  28. Maridonneau-Parini I, Harpey C. Effects of trimetazidine on membrane damage induced by oxygen free radicals in human red cells. Br J Clin Pharmacol. 1985;20:148–151
  29. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P. Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J Mol Cell Cardiol. 1994;26:949–958
  30. Boucher FR, Hearse DJ, Opie LH. Effects of trimetazidine on ischemic contracture in isolated rat hearts. J Cardiovasc Pharmacol. 1994;24:45–49
  31. Raev DC. Which left ventricular function is impaired earlier in the evaluation of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients. Diabetes Care. 1994;17:633–639
  32. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalance of diastolic dysfunction in normotensive asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol. 2001;87:320–323
  33. Liedtke AJ, Demaison AM, Eggleston LM, Cohen SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res. 1988;62:535–542
  34. Lagadic-Gossmann D, Le Prigent K, Feuvray D. Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte. Br J Pharmacol. 1996;117:831–838
  35. Yorek MA. The role of oxidative stress in diabetic vascular and neural disease. Free Radic Res. 2003;37:471–480
  36. Castedo E, Segovia J, Escudero C, Olmedilla B, Granado F, Blas C, et al. Ischemia-reperfusion injury during experimental heart transplantation. Evaluation of trimetazidine's cytoprotective effect. Rev Esp Cardiol. 2005;58(8):941–950

PII: S0188-4409(06)00088-9

doi: 10.1016/j.arcmed.2006.01.008

Archives of Medical Research
Volume 37, Issue 6 , Pages 700-708 , August 2006

Article Tools

* Image Usage & Resolution